Titlebook: Radiation Therapy Physics; Alfred R. Smith (Radiation Biophysicist) Book 1995 Springer-Verlag Berlin Heidelberg 1995 Biophysik.Dosimetrie.

共棲

Electron Beam Dose Calculations,thy tis-sues beyond the treatment volume. Electron dosecalculation algorithms are required for clinical treat-ment planning, and in conjunction with computed tomography (CT) scan data they can potentially be made quite accurate. Unfortunately, it is not yet pos-sible to routinely calculate the absor

PURG

Clinical Electron Beam Physics,get tissues. With photon beam planning, the beam is exponen-tially absorbed by the tissues beyond the target depth, whereas the finite range of electrons provides a powerful tool for limiting the dose to deep-seated tissues. As always, with any advantage comes disad-vantage. With electrons, these di

愚蠢人

adj憂郁的

吞下

Computer-Controlled 3D Conformal Radiation Therapy,ately than traditional methods. One of the most important applications is in the delivery of conformal treatments for which the goal of maximizing the dose to the tumor and minimizing the dose to normal structures often leads to treatment plans of complex design. Although conformal therapy has alway

cogent

External Beam Stereotactic Radiosurgery Physics, radiation beams, such as x-rays or gamma rays, eliminating the need for conventional invasive surgery. Stereotactic radiation therapy (SRT) is the treatment of intracranial lesions with the stereotactic apparatus and multiple fractions. A stereotactic frame allows for rigid immobilization of the pa

殘廢的火焰

Treatment Optimization Using Physical and Radiobiological Objective Functions,This is fortunate because a chain is only as strong as its weakest link, and significant developments in one single area are not always sufficient for general improvements of the overall performance. The development of radiation therapy planning during the last decade has been enormous. We have witn

Pelvic-Floor

終點(diǎn)

backdrop

Dosimetry of Radiolabeled Antibodies,etastatic disease with a variety of agents including hormones, transmitters, drugs, metabolites, and polyclonal antibodies (. 1968). Naturally, if it was found that any of these agents were not sufficiently cytotoxic to the tumor, a radionuclide label was added to promote selective tumor lethality a